<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02523573</url>
  </required_header>
  <id_info>
    <org_study_id>HLM_JDR4</org_study_id>
    <nct_id>NCT02523573</nct_id>
  </id_info>
  <brief_title>Study of High Flow Nasal Cannula Oxygen for Bronchoscopy With Bronchoalveolar Lavage in ICU Patients</brief_title>
  <acronym>Optibal</acronym>
  <official_title>High Flow Nasal Oxygen for Bronchoscopy With Bronchoalveolar Lavage in Acute Respiratory Failure Patients: the OptiBAL Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hôpital Louis Mourier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Tenon Hospital, Paris</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Henri Mondor University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hopital Antoine Beclere</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hôpital Louis Mourier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Bronchoscopy with bronchoalveolar lavage (BAL) is at risk for worsening hypoxemia in patients
      with acute respiratory failure (ARF). High-flow nasal cannula oxygen (HFNC) improves
      hypoxemia in ARF patients . We investigated its efficacy and tolerance in intensive care unit
      patients admitted for ARF requiring BAL.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective, observational, multicenter study in ARF patients (minimal pulse oximetry -SpO2-
      of 92% with an minimal oxygen flow of 6 L/min , respiratory rate &gt; 25/min (20/min if use of
      accessory respiratory muscles) with a compatible etiology. Primary outcome measure is
      increase in ventilatory support (non-invasive positive pressure ventilation (NPPV) or
      endotracheal intubation (ETI)) within the first 24h following BAL.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Actual">September 2015</completion_date>
  <primary_completion_date type="Actual">September 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>increase in ventilatory support</measure>
    <time_frame>24h</time_frame>
    <description>increase in ventilatory support (non-invasive positive pressure ventilation (NPPV) or endotracheal intubation (ETI)) within the first 24h following BAL</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Immediate tolerance of bronchoscopy and BAL</measure>
    <time_frame>12h</time_frame>
    <description>Vital signs, dyspnea score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operator's satisfaction</measure>
    <time_frame>15min</time_frame>
    <description>Physician performing the BAL procedure rated their comfort with HFNC from 0 to 10</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Diagnosis yield of BAL</measure>
    <time_frame>48h</time_frame>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">30</enrollment>
  <condition>Respiratory Insufficiency</condition>
  <arm_group>
    <arm_group_label>Study population</arm_group_label>
    <description>Adult ARF ICU patients needing BAL with HFNC</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Adult ARF ICU patients needing BAL with HFNC</intervention_name>
    <description>bronchoalveolar lavage is performed in spontaneously breathing patients under high flow nasal cannula oxygen</description>
    <arm_group_label>Study population</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients admitted to the Intensive Care Unit, with acute hypoxemic respiratory
        failure requiring bronchoalveolar lavage
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  presence of acute respiratory failure: defined as respiratory rate greater than
             25/min, (or greater than 20/min if use of accessory respiratory muscles was present),
             in patients requiring oxygen greater than or equal to 6 L/min to obtain a pulse
             oximetry greater than 92%

          -  need for bronchoalveolar lavage (decision to perform BAL was left at the physician's
             discretion)

        Exclusion Criteria:

          -  at least one contraindication to the bronchoscopy with BAL: acute coronary syndrome
             within 6 weeks; neurologic failure; thrombocytopenia less than 30 000/mm3; respiratory
             acidosis with a pH lower than 7.30 or hypercapnia higher than 60 mmHg; pneumothorax
             undrained.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Beatrice La Combe, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hopital Antoine Béclère</name>
      <address>
        <city>Clamart</city>
        <zip>92</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Louis Mourier Hospital</name>
      <address>
        <city>Colombes</city>
        <zip>92700</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Henri Mondor</name>
      <address>
        <city>Creteil</city>
        <zip>94000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Tenon</name>
      <address>
        <city>Paris</city>
        <zip>75020</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Messika J, Ben Ahmed K, Gaudry S, Miguel-Montanes R, Rafat C, Sztrymf B, Dreyfuss D, Ricard JD. Use of High-Flow Nasal Cannula Oxygen Therapy in Subjects With ARDS: A 1-Year Observational Study. Respir Care. 2015 Feb;60(2):162-9. doi: 10.4187/respcare.03423. Epub 2014 Nov 4.</citation>
    <PMID>25371400</PMID>
  </reference>
  <reference>
    <citation>Ricard JD. High flow nasal oxygen in acute respiratory failure. Minerva Anestesiol. 2012 Jul;78(7):836-41. Epub 2012 Apr 24. Review.</citation>
    <PMID>22531566</PMID>
  </reference>
  <reference>
    <citation>Sztrymf B, Messika J, Bertrand F, Hurel D, Leon R, Dreyfuss D, Ricard JD. Beneficial effects of humidified high flow nasal oxygen in critical care patients: a prospective pilot study. Intensive Care Med. 2011 Nov;37(11):1780-6. doi: 10.1007/s00134-011-2354-6. Epub 2011 Sep 27.</citation>
    <PMID>21946925</PMID>
  </reference>
  <results_reference>
    <citation>Simon M, Braune S, Frings D, Wiontzek AK, Klose H, Kluge S. High-flow nasal cannula oxygen versus non-invasive ventilation in patients with acute hypoxaemic respiratory failure undergoing flexible bronchoscopy--a prospective randomised trial. Crit Care. 2014 Dec 22;18(6):712. doi: 10.1186/s13054-014-0712-9.</citation>
    <PMID>25529351</PMID>
  </results_reference>
  <results_reference>
    <citation>Lucangelo U, Vassallo FG, Marras E, Ferluga M, Beziza E, Comuzzi L, Berlot G, Zin WA. High-flow nasal interface improves oxygenation in patients undergoing bronchoscopy. Crit Care Res Pract. 2012;2012:506382. doi: 10.1155/2012/506382. Epub 2012 May 20.</citation>
    <PMID>22666567</PMID>
  </results_reference>
  <results_reference>
    <citation>Maitre B, Jaber S, Maggiore SM, Bergot E, Richard JC, Bakthiari H, Housset B, Boussignac G, Brochard L. Continuous positive airway pressure during fiberoptic bronchoscopy in hypoxemic patients. A randomized double-blind study using a new device. Am J Respir Crit Care Med. 2000 Sep;162(3 Pt 1):1063-7.</citation>
    <PMID>10988131</PMID>
  </results_reference>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 13, 2015</study_first_submitted>
  <study_first_submitted_qc>August 13, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 14, 2015</study_first_posted>
  <last_update_submitted>February 25, 2016</last_update_submitted>
  <last_update_submitted_qc>February 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hôpital Louis Mourier</investigator_affiliation>
    <investigator_full_name>Prof Jean-Damien RICARD</investigator_full_name>
    <investigator_title>Professor of Intensive Care Medicine, Assistant Head of Medico-Surgical ICU</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Pulmonary Valve Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

